EUVIMEDDescoperă EUVIMED
Randomisierte kontrollierte StudieValidierungsstudieOpen access

Validating the Efficacy of a Mobile Digital Therapeutic for Insomnia (WELT-I): Randomized Controlled Decentralized Clinical Trial

Validierung der Wirksamkeit einer mobilen digitalen Therapeutik bei Insomnie (WELT-I): randomisierte kontrollierte dezentrale klinische Studie

Kyung Mee Park, Suonaa Lee, Yujin Lee, Daa Un Moon, Eun Lee

Journal of Medical Internet Research · 2025-09-23 · 27 · e70722-e70722

DOI: 10.2196/70722 ↗

Auf einen Blick

WELT-I verbesserte in einer 6-wöchigen Studie die Schlafeffizienz gegenüber einer Schein-App. Auch dysfunktionale Überzeugungen zum Schlaf nahmen stärker ab.

Fragestellung

Wirksamkeit und Sicherheit von WELT-I bei Insomnie und Eignung eines dezentralen klinischen Studien-Designs zur Validierung digitaler Therapeutika.

Methode

Doppelblinde, sham-kontrollierte randomisierte DCT bei Personen mit Insomnie; 6 Wochen Nutzung von WELT-I oder Schein-App; Messung per App-Tagebuch und Fragebögen.

Ergebnisse

68 randomisiert; 54 in der Auswertung. Schlafeffizienz: least-squares difference 8,28; P=.04. Dysfunktionale Überzeugungen über Schlaf: least-squares difference −1,03; P=.008.

Schlussfolgerung der Autor:innen

WELT-I zeigte laut Autor:innen therapeutische Wirksamkeit und Sicherheit bei Insomnie. Die Studie spricht auch für die Machbarkeit von DCTs zur Prüfung digitaler Therapeutika.

Kernaussagen

  • Schlafeffizienz unter WELT-I verbessert
  • Dysfunktionale Schlafüberzeugungen nahmen stärker ab
  • Dezentrales Studiendesign mit hoher Compliance und Retention

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in Journal of Medical Internet Research, published online on 2025-09-23. Written by Kyung Mee Park and 4 co-authors. Institution: Department of Hospital Medicine, Yongin Severance Hospital, Yongin, Republic of Korea. Major MEDLINE topics: Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Mobile Applications. Cited 5 times so far (Crossref); 70 references. The full text is freely available in PubMed Central.

Auf einen BlickRezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Cognitive behavioral therapy for insomnia (CBT-I) has proven to be an effective treatment; however, its accessibility is limited. To address this issue, digital therapeutics for insomnia (DTx-Is), which are software-driven interventions designed to treat insomnia based on CBT-I, have emerged as a potential solution to enhance access.

Objective

This study aimed to verify the efficacy and safety of WELT-I, a DTx-I. Due to the impact of the global pandemic during the study period, we thought that a decentralized clinical trial (DCT) design that does not require visits to institutions would be appropriate for a clinical study of a digital therapeutic for patients with insomnia. Thus, we also examined the potential of the DCT design as an effective method for validating DTx-Is.

Methods

A double-blind, sham-controlled randomized DCT was conducted with participants who met the diagnostic criteria for insomnia. Participants were recruited through advertisements posted on an open-access website. WELT-I is a DTx-I based on CBT-I. A sham app was engineered to mirror WELT-I’s installation, login, user engagement, and content delivery processes while maintaining double-blind protocols. After randomization, participants were asked to use WELT-I or the sham app for 6 weeks. All treatment processes were fully automated. Sleep parameters were measured through an app-based sleep diary. Self-report questionnaires on sleep, depression, and anxiety were administered via the app at baseline and the end of the study. The primary outcome was sleep efficiency. To investigate the feasibility of the DCT design, compliance, retention rate, participant satisfaction, and time to reach the recruitment goal were evaluated.

Results

A total of 89 participants provided consent and underwent screening, and 68 participants were randomly assigned to the WELT-I group (n=33) or control group (n=35). Among them, 14 participants discontinued the trial, leaving 54 participants who completed the study and were included in the final analysis (28 in the WELT-I group and 26 in the control group). WELT-I significantly improved sleep efficiency (least-squares difference=8.28; P =.04) and dysfunctional beliefs about sleep (least-squares difference=−1.03; P =.008) compared with the sham app. The study completed recruitment in 73 days, and the compliance rate was 95% (186/196) in the WELT-I group and 91% (165/182) in the control group. Moreover, the retention rate was 82% (23/28), and the average satisfaction score was 7.2 out of 10.

Conclusions

WELT-I showed significant therapeutic efficacy and safety in improving sleep efficiency and sleep-related dysfunctional attitudes in cases of insomnia. In addition, this study demonstrated the feasibility of DCTs, and the findings of rapid recruitment, high compliance and retention rates, and strong participant satisfaction suggest that DCTs have sufficient potential to be expanded to clinical studies verifying the efficacy of other DTx-Is in the future.

Subjects

MeSH terms (MEDLINE)

Sleep Initiation and Maintenance DisordersCognitive Behavioral TherapyMobile ApplicationsHumansMaleFemaleAdultMiddle AgedDouble-Blind MethodTelemedicineTreatment Outcome

Author keywords

behavioral sleep medicinecognitive behavioral therapydecentralized clinical trialdigital interventiondigital therapeuticsdigital therapeutics for insomniainsomniamHealthmobile health

Authors and institutions

  • Department of Hospital Medicine, Yongin Severance Hospital, Yongin, Republic of Korea.
  • Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea, 82 2 2228 1620.
  • Department of Pharmacy, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea.
  • WELT Corp, Seoul, Republic of Korea.
  • Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Cite

APA

Park, K. M., Lee, S., Lee, Y., Moon, D. U., & Lee, E. (2025). Validating the Efficacy of a Mobile Digital Therapeutic for Insomnia (WELT-I): Randomized Controlled Decentralized Clinical Trial. Journal of Medical Internet Research, 27, e70722-e70722. https://doi.org/10.2196/70722

Vancouver

Park KM, Lee S, Lee Y, Moon DU, Lee E. Validating the Efficacy of a Mobile Digital Therapeutic for Insomnia (WELT-I): Randomized Controlled Decentralized Clinical Trial. Journal of Medical Internet Research. 2025;27:e70722-e70722. doi:10.2196/70722

BibTeX
@article{Park2025,
  author = {Park, Kyung Mee and Lee, Suonaa and Lee, Yujin and Moon, Daa Un and Lee, Eun},
  title = {Validating the Efficacy of a Mobile Digital Therapeutic for Insomnia (WELT-I): Randomized Controlled Decentralized Clinical Trial},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e70722--e70722},
  doi = {10.2196/70722}
}
Start for free →